C0376636||Successful Management
C0019069||Hemophilia A
C0030805||Bullous Pemphigoid
C0085973||Case Report
C0282441||Review of the Literature
C0019069||hemophilia A
C0019069||Acquired hemophilia A
C0678236||rare condition
C0475463||neutralizing antibodies
C0032961||pregnancy
C0004364||autoimmune diseases
C4282132||malignancies
C0041755||adverse drug reactions
C1457887||Symptoms
C0019080||bleeding
C2826244||life-threatening
C0085973||Case Study
C0684224||report
C0019069||Acquired hemophilia A
C0030805||bullous pemphigoid
C0030805||bullous pemphigoid
C0004368||autoimmune
C1856956||subepidermal
C4314154||blistering skin disease
C1301725||documented
C0087111||treatment
C0025815||methylprednisolone
C0442797||decreasing
C0393022||rituximab
C0003250||monoclonal antibody
C1447954||CD20 protein
C0019069||Acquired hemophilia A
C0030805||bullous pemphigoid
C0684224||report
C0019069||Acquired hemophilia A
C0030805||bullous pemphigoid
C3178994||eradicating
C0087111||treatment